The authors confirmed that SIGLEC9+ CD4+T, SIGLEC9+CD8+T-cells and SIGLEC9+ M2 macrophages in cervical cancer tissues were higher than those in normal controls (Fig. 7G‒I). The gene discussed is CD4; the disease is cervical cancer.